• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠心病患者支架内再狭窄风险的预测评分模型

Predictive Scoring Model for In-Stent Restenosis Risk in Coronary Artery Disease Patients.

作者信息

Wang Pan, Xu Juan

机构信息

Department of Internal Medicine, Peking University Shougang Hospital, Beijing, China.

出版信息

Med Sci Monit. 2025 Jun 11;31:e947986. doi: 10.12659/MSM.947986.

DOI:10.12659/MSM.947986
PMID:40495366
Abstract

BACKGROUND In-stent restenosis (ISR) after coronary stent implantation is a significant clinical challenge in patients with coronary artery disease (CAD). In this study we identified independent risk factors for ISR and developed a predictive scoring model based on these factors. MATERIAL AND METHODS We conducted a retrospective study of 256 CAD patients who underwent percutaneous coronary intervention (PCI) from January 2017 to December 2018. Based on follow-up angiography, patients were classified into ISR and non-ISR groups. Logistic regression analysis was used to identify independent predictors, and an ISR scoring model was developed. Receiver operating characteristic (ROC) curve analysis assessed predictive performance. RESULTS Compared to the non-ISR group, the ISR group had significantly higher levels of LDL-C, D-dimer, HbA1c, and uric acid (all P<0.01), along with higher rates of post-procedural smoking, poor blood pressure control, and family history of CAD. Logistic regression analysis identified elevated LDL-C (OR: 5.074), D-dimer (OR: 3.381), HbA1c (OR: 5.322), post-procedural smoking (OR: 4.364), and poor blood pressure control (OR: 5.168) as independent risk factors (all P<0.05). LDL-C showed the highest predictive value (AUC: 0.9289). The ISR scoring model achieved an AUC of 0.8643, with 85.8% sensitivity and 73.9% specificity at a cut-off of 3.0 points. CONCLUSIONS Elevated LDL-C, D-dimer, HbA1c, post-procedural smoking, poor blood pressure control, and a family history of CAD were independent risk factors for ISR. The ISR scoring model provides a practical tool for predicting ISR risk and guiding clinical management to improve outcomes in patients undergoing PCI.

摘要

背景

冠状动脉支架植入术后的支架内再狭窄(ISR)是冠心病(CAD)患者面临的一项重大临床挑战。在本研究中,我们确定了ISR的独立危险因素,并基于这些因素开发了一个预测评分模型。

材料与方法

我们对2017年1月至2018年12月期间接受经皮冠状动脉介入治疗(PCI)的256例CAD患者进行了一项回顾性研究。根据随访血管造影结果,将患者分为ISR组和非ISR组。采用逻辑回归分析确定独立预测因素,并开发了一个ISR评分模型。采用受试者工作特征(ROC)曲线分析评估预测性能。

结果

与非ISR组相比,ISR组的低密度脂蛋白胆固醇(LDL-C)、D-二聚体、糖化血红蛋白(HbA1c)和尿酸水平显著更高(均P<0.01),术后吸烟率、血压控制不佳率和CAD家族史也更高。逻辑回归分析确定LDL-C升高(比值比:5.074)、D-二聚体(比值比:3.381)、HbA1c(比值比:5.322)、术后吸烟(比值比:4.364)和血压控制不佳(比值比:5.168)为独立危险因素(均P<0.05)。LDL-C显示出最高的预测价值(曲线下面积:0.9289)。ISR评分模型的曲线下面积为0.8643,在截断值为3.0分时,敏感性为85.8%,特异性为73.9%。

结论

LDL-C升高、D-二聚体、HbA1c、术后吸烟、血压控制不佳和CAD家族史是ISR的独立危险因素。ISR评分模型为预测ISR风险和指导临床管理以改善接受PCI患者的预后提供了一个实用工具。

相似文献

1
Predictive Scoring Model for In-Stent Restenosis Risk in Coronary Artery Disease Patients.冠心病患者支架内再狭窄风险的预测评分模型
Med Sci Monit. 2025 Jun 11;31:e947986. doi: 10.12659/MSM.947986.
2
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.二代药物洗脱支架置入术后三血管病变患者血运重建和支架内再狭窄的危险因素:回顾性分析。
BMC Cardiovasc Disord. 2021 Sep 17;21(1):446. doi: 10.1186/s12872-021-02259-0.
3
Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention.血浆 Quaking 和环氧化酶-2 水平可预测经皮冠状动脉介入治疗后冠心病患者的支架内再狭窄。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jun 28;47(6):739-747. doi: 10.11817/j.issn.1672-7347.2022.210716.
4
Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent.卡特利评分系统作为接受药物洗脱支架经皮冠状动脉介入治疗的慢性冠状动脉疾病患者支架内再狭窄的一种新预测指标。
J Cardiothorac Surg. 2025 Jan 29;20(1):106. doi: 10.1186/s13019-025-03349-2.
5
The Relationship Between Serum SFRP5, ApoA-I, HDL3-C Level and In-Stent Restenosis After PCI in Acute Myocardial Infarction and the Combined Predictive Value.急性心肌梗死患者PCI术后血清SFRP5、载脂蛋白A-I、HDL3-C水平与支架内再狭窄的关系及联合预测价值
Kaohsiung J Med Sci. 2025 May;41(5):e70000. doi: 10.1002/kjm2.70000. Epub 2025 Mar 8.
6
CHADS-Vasc score and CHADS-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents.CHADS-Vasc评分和CHADS-Vasc-HS评分在接受冠状动脉药物洗脱支架治疗的患者中,对支架内再狭窄的预测能力较差。
J Int Med Res. 2019 Jun;47(6):2533-2544. doi: 10.1177/0300060519841836. Epub 2019 Apr 30.
7
Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.用于预测支架内再狭窄的冠状动脉CT血管造影衍生的定量标志物。
J Cardiovasc Comput Tomogr. 2016 Sep-Oct;10(5):377-83. doi: 10.1016/j.jcct.2016.07.005. Epub 2016 Jul 6.
8
Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease.分析单核细胞/高密度脂蛋白胆固醇比值与早发冠心病患者支架内再狭窄的相关性。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221079334. doi: 10.1177/10760296221079334.
9
Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.在接受经皮冠状动脉介入治疗的 2 型糖尿病患者中,残脂蛋白在支架内再狭窄中起重要作用:一项单中心观察性队列研究。
Cardiovasc Diabetol. 2019 Jan 28;18(1):11. doi: 10.1186/s12933-019-0819-z.
10
Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.尿酸与白蛋白比值与冠心病经药物洗脱支架置入术后支架内再狭窄的关系。
Coron Artery Dis. 2023 Dec 1;34(8):589-594. doi: 10.1097/MCA.0000000000001300. Epub 2023 Oct 11.

本文引用的文献

1
The Complex Inflammatory and Nutritional Indices to Predict Prognostic Risk for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.预测接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者预后风险的复杂炎症和营养指标
Immun Inflamm Dis. 2025 Mar;13(3):e70180. doi: 10.1002/iid3.70180.
2
The impact of drug eluting stents on the co-release of interleukin-6 in patients with stable angina.药物洗脱支架对稳定型心绞痛患者白细胞介素-6共释放的影响。
Glob Cardiol Sci Pract. 2024 Dec 31;2024(6):e202453. doi: 10.21542/gcsp.2024.53.
3
In-Stent Restenosis: Is the Future Bioresorbable?
支架内再狭窄:未来会是生物可吸收的吗?
JACC Cardiovasc Interv. 2024 Aug 12;17(15):1837-1839. doi: 10.1016/j.jcin.2024.06.018.
4
Complex and High-Risk Percutaneous Coronary Intervention at Centers With No Surgical Back-Up: Are We Ready for Prime Time?在没有外科手术支持的中心进行复杂高危经皮冠状动脉介入治疗:我们准备好迎接黄金时代了吗?
Can J Cardiol. 2024 Jul;40(7):1247-1249. doi: 10.1016/j.cjca.2024.02.007. Epub 2024 Feb 17.
5
Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery.经皮冠状动脉介入治疗新发病变涉及左回旋支开口的临床和操作结果。
Catheter Cardiovasc Interv. 2023 Nov;102(6):1048-1056. doi: 10.1002/ccd.30903. Epub 2023 Nov 7.
6
Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.尿酸与白蛋白比值与冠心病经药物洗脱支架置入术后支架内再狭窄的关系。
Coron Artery Dis. 2023 Dec 1;34(8):589-594. doi: 10.1097/MCA.0000000000001300. Epub 2023 Oct 11.
7
Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis.识别有症状颅内动脉粥样硬化性狭窄患者支架内再狭窄的危险因素:一项系统评价和荟萃分析。
Front Neurol. 2023 Jul 14;14:1170110. doi: 10.3389/fneur.2023.1170110. eCollection 2023.
8
Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis.甘油三酯-葡萄糖指数与冠状动脉疾病:风险、严重程度和预后的系统评价和荟萃分析。
Cardiovasc Diabetol. 2023 Jul 6;22(1):170. doi: 10.1186/s12933-023-01906-4.
9
Drug-Coated Balloon in Primary Percutaneous Coronary Intervention.药物涂层球囊在原发性经皮冠状动脉介入治疗中的应用。
J Interv Cardiol. 2023 Jun 26;2023:5210808. doi: 10.1155/2023/5210808. eCollection 2023.
10
Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review.经皮冠状动脉介入治疗患者的冠状动脉疾病护理路径中的挑战和负担:当代叙事性综述。
Int J Environ Res Public Health. 2023 Apr 25;20(9):5633. doi: 10.3390/ijerph20095633.